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TO THE EDITOR
Epidermolysis bullosa (EB) encom-
passes a heterogeneous group of here-
ditary disorders characterized by blis-
tering of the skin upon exposure to
mechanical stress. EB simplex (EBS) is
the most common form of EB and the
first keratin disorder whose genetic
basis was elucidated in humans (Uitto
et al., 2007).
EBS has been associated with muta-
tions in at least eight distinct genes
(Intong and Murrell, 2012). Although
the very rare forms of superficial EBS
have been associated with mutations in
PKP1 and DSP encoding plakophilin 1
and desmoplakin (Jonkman et al., 2005;
McGrath and Mellerio, 2010), the more
common type of EBS is usually due to
mutations in KRT5 and KRT14 encoding
basal cell keratins (Sprecher, 2010),
although it is occasionally caused by
mutations in other genes including
PLEC1, ITGA6, ITGB4, and DST (Jonk-
man et al., 2002; Pfendner et al., 2005a;
Groves et al., 2010). K5 and K14
assemble into 10-nm keratin intermedi-
ate filaments that underlie the formation
of the cytoskeleton of epithelial cells
(Candi et al., 2005). Most KRT5 and
KRT14 mutations have been shown to
disrupt the central a-helical segment of
these molecules, thereby leading to
reduced resistance to mechanical stress
and skin blistering, although other
mechanisms may underlie rare pheno-
types caused by mutations affecting less
well-conserved areas of the keratin
molecules (Uttam et al., 1996; Gu
et al., 2003; Sprecher et al., 2003).
EBS caused by mutations in KRT5 or
KRT14 is usually inherited as an auto-
somal dominant trait. Occasionally,
especially in populations characterized
by an elevated coefficient of inbreed-
ing, autosomal recessive inheritance is
common (Abu Sa’d et al., 2006). In the
present report, we describe a hitherto
reported form of recessive inheritance
in EBS.
A 2-year-old boy of Jewish Ashkenazi
origin was referred to our outpatient
clinic because of widespread congenital
skin blistering (EBS—other generalized).
His parents noticed marked exacerba-
tion during the summer months. His
mother as well as maternal grandfather
reported a similar but significantly
milder phenotype. These two indivi-
duals demonstrated blisters, mostly dur-
ing the summer period and exclusively
located on the soles. The grandparents
of the proband confirmed that his
mother was only mildly affected from
early childhood. The father of the
proband was totally asymptomatic. On
examination, tensed bullae were ob-
served over the dorsal surface of the
feet, the legs (Figure 1a), and along the
trunk. No milia, mucosal involvement,
or nail dystrophy were observed. Exam-
ination of the mother and maternal
grandfather of the proband failed on
several occasions to reveal active signs
of disease. A skin biopsy showed sub-
epidermal blister formation, whereas
immunohistochemical staining demon-
strated keratin staining at the base and
roof of the blister (not shown).
The family provided written and
informed consent according to a proto-
col approved by the National Commit-
tee for Genetic Studies of the Israeli
Ministry of Health in accordance with
the Declaration of Helsinki guidelines.
DNA was extracted from peripheral
blood leukocytes using the 5 Prime
ArchivePure DNA Blood Kit (5 Prime,
Gaithersburg, MD). In an attempt to
explain the striking phenotypic discre-
pancy between the proband and other
affected members of his family, we
screened all family members for muta-
tions in KRT5 and KRT14. Genomic
DNA was PCR-amplified using primer
pairs spanning the entire coding se-
quence, as well as intron–exon bound-
aries of KRT5 and KRT14, as previously
described (Whittock et al., 2000; Ciu-
botaru et al., 2003).
The proband and his asymptomatic
father were found to carry a hetero-
zygous G-A transition at position 1163
of the KRT14 complementary DNA
(cDNA). This mutation results in the
substitution of a histidine for an arginine
at amino acid position 388 (p.R388H,
Figure 1b). This mutation has previously
been associated with recessive inheri-
tance of EBS in a compound hetero-
zygous state (Ciubotaru et al., 2003). In
addition, the proband was found to carry
a heterozygous T-C transition at posi-
tion 548 of the KRT5 cDNA. This
mutation results in the substitution of
threonine for isoleucine, p.I183T (Figure
1b), affecting a highly conserved amino-
acid residue (Figure 1d, Conseq¼9,
range 1–9; http://conseq.tau.ac.il/) of
predicted functional importance (Poly-
Phen-2¼1, range 1–0, http://genet-
ics.bwh.harvard.edu/pph2/index.shtml;
SIFT¼0, range 1–0, http://sift.jcvi.org/).
The mildly affected mother and maternal
grandfather of the proband also carried
the same mutation in a heterozygous
state (Figure 1b). Using PCR–restriction
fragment length polymorphism assays,
we confirmed segregation of the muta-
tions with the disease phenotype in the
family (Figure 1c) and excluded p.I183T
from a panel of 200 population-matched
control individuals (400 alleles).
The two missense mutations identi-
fied in this study, p.I183T and p.R388H,
are both located in highly conserved
regions within the 1A domain of K5
and 2B domain of K14, respectively. As
the two molecules form under physio-
logical conditions a heterodimer
(Coulombe et al., 2009), the presence
of mutations in both K5 and K14 is
likely to aggravate the consequences of
each separate mutation. p.R388H has
been reported previously in three
cases of EBS. In the first study, it was
shown that p.R388H causes EBS-WeberAbbreviations: cDNA, complementary DNA; EB, epidermolysis bullosa; EBS, EB simplex
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Cockayne in a compound heterozygous
state with another nonsense mutation in
KRT14 whereas it was phenotypically
silent in the father of the affected
children (Ciubotaru et al., 2003). Abu
Sa’d et al. (2006) identified two patients
with EBS-Weber Cockayne carrying
p.R388H in a heterozygous state with
no other mutations in KRT5 or KRT14,
suggesting partial penetrance and/or the
effect of modifying factors (Ciubotaru
et al., 2003; Abu Sa’d et al., 2006).
Several heterozygous mutations have
previously been shown to affect codon
183 of KRT5. The mutations p.I183F
(Pfendner et al., 2005b) or p.I183M
(Chamcheu et al., 2010) results in a
severe form of EBS, whereas p.I183V
(Glasz-Bona et al., 2009) or p.I183T (this
study) results in a milder phenotype. The
severity of the phenotype is probably
influenced by the size of the substituted
amino acid, as phenylalanine and
methionine have a larger side chain
compared with valine and threonine.
Clearly, digenic inheritance together
with other modifying traits (Titeux et al.,
2008) may explain in part the highly
variable phenotype typical of EB in
general, and of EBS more specifically
(Sprecher, 2010). The first example of
digenic inheritance of a human pheno-
type was reported in a case of retinitis
pigmentosa (Kajiwara et al., 1994).
Since then, similar cases have been
described in many monogenic disor-
ders including nonsyndromic deafness,
Bardet–Biedl syndrome, and Waarden-
burg syndrome type II (reviewed in
Badano and Katsanis, 2002).
Digenic inheritance has been re-
ported in a severe case of junctional
EB, in which two mutations in the
COL17A gene and one mutation in
the LAMB3 gene were detected and
found to be associated with abnormal
expression of two functionally related
proteins, collagen XVII and laminin 332
(Floeth and Bruckner-Tuderman, 1999).
It is of interest that in this case hetero-
zygous carriers of one COL17A1 muta-
tion and of one LAMB3 mutation were
asymptomatic (Floeth and Bruckner-
Tuderman, 1999).
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Figure 1. Clinical features and molecular analysis in a family with epidermolysis bullosa simplex. (a) Severe and widespread blistering in patient III-1. (b) Sequence
analysis reveals a heterozygous G4A at complementary DNA (cDNA) position 1163 of the KRT14 gene in the proband (upper panel) and his asymptomatic
father (middle panel) resulting in p.R388H substitution, as well as a heterozygous T4C transition at cDNA position 548 of the KRT5 gene resulting in p.I183T
substitution in the proband (upper panel) and his mother (lower panel); the p.I183T and p.R388H are marked with an arrow. (c) To confirm segregation of mutation
p.I183T with the disease in the family, a 259-bp-long PCR-amplified DNA fragment (forward primer 50-CAAATCGACCCCAGCATCCA-30; reverse primer 50-CAGT
CTAATTCAGAACGTGTCC-30) was digested overnight at 65 1C with DNA endonuclease TaqaI: carriers of the mutation display a 259-bp fragment, whereas
noncarriers show a 176-bp fragment only. To confirm segregation of mutation p.R388H with the disease in the family, we used a PCR–restriction fragment length
polymorphism assay previously described (Ciubotaru et al., 2003; Abu Sa’d et al., 2006). (d) Conseq analysis attributes a maximal conservation score to residue I183
(http://conseq.tau.ac.il/). I183 is marked with an arrow.
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A patient with EBS and his affected
mother were also found to carry
mutations in two distinct EB-asso-
ciated genes, KRT5 (p.E168D) and
KRT14 (p.A413T) (Murrell et al.,
2011). The fact that the p.E168D in
KRT5 mutation reported in this study
affects a highly conserved residue,
involved in another EBS-causing muta-
tion (p.E168K; Muller et al., 2006),
supports a potential pathogenic role
for this mutation in causing a disease
phenotype. In contrast, p.A413T is
most likely a polymorphism of no
consequence, as this sequence altera-
tion was found in a substantial number
of healthy controls in a heterozygous
state (5% of a control population); a
healthy individual was found to carry
p.A413T in a homozygous state; bio-
informatic analysis predicts lack of
effect of the p.A413T change on K14
structure; and in contrast with p.
A413P, p.A413T did not have any
deleterious effect on keratin filament
formation as assayed in vitro (Natsuga
et al., 2011). In addition, looking more
carefully at the data, Murrell et al.
(2011) even suggested that p.A413T
may have a protective effect, which in
turn may explain the fact that this
polymorphism has been maintained
through evolution. Thus, these data
suggest that digenic inheritance was
not directly involved in causing/modi-
fying the clinical phenotype in the
above case.
In conclusion, we provide evidence
implicating digenic inheritance in de-
termining a clinical phenotype in EBS,
suggesting that full sequencing of all
EBS-associated genes may improve the
quality of genetic counseling in this
clinically heterogeneous disease.
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